Middle East Biliary Tract Cancer Market: Current Analysis and Forecast (2023-2030)
Emphasis on Treatment Type (Chemotherapy, Targeted Therapy, and Others); Route of Administration (Inhalation, Intravenous, Intranasal, Subcutaneous, Oral, and Parenteral); and Region/Country
The Middle East Biliary Tract Cancers (BTCs) market was valued at USD 70 Million in the year 2022 and is expected to grow at a strong CAGR of around 5% during the forecast period (2022-2030). Biliary Tract Cancer can occur in any part of the bile duct system, including the intrahepatic bile ducts (inside the liver), the extrahepatic bile ducts (outside the liver), and the cystic duct and common bile duct, which connect the liver and gallbladder. The middle east biliary tract cancer market encompasses the pharmaceutical and healthcare sectors related to the diagnosis, treatment, and management of cancers that originate in the bile ducts, gallbladder, and other parts of the biliary tract. The increasing prevalence of cancers and gall bladder disorders are the major reasons responsible for the growth of the market.
Some of the major players operating in the market include Incyte; Eisai Co., Ltd.; QED Therapeutics; Agios Pharmaceuticals, Inc.; RenovoRx; Ability Pharma; Purdue Pharmaceuticals L.P.; Delcath Systems, Inc; and Basilea Pharmaceutica Ltd. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst treatment types, the targeted therapy segment held the highest CAGR during the forecast period”
Based on treatment type, the market is segmented into chemotherapy, targeted therapy, and others. Amongst these, the targeted therapy segment held the highest CAGR during the forecast period. The use of targeted therapy for biliary tract cancer is expected to increase in the coming years, as more effective drugs and targets are identified through research and development. For example, the TKI erlotinib has been approved for the treatment of biliary tract cancer, and the immunotherapy drug pembrolizumab is also being investigated for the treatment of this disease.
“Amongst route of administration, specialty stores held the majority share of the market in 2022”
Based on the route of administration, the middle east biliary tract cancers (BTCs) market has been classified into inhalation, intravenous, intranasal, subcutaneous, oral, and parenteral. Among these, oral captured the majority share of the middle east biliary tract cancers (BTCs) market in 2022. The oral route of administration involves the use of drugs that are taken by mouth, rather than injected or administered through other routes. This type of treatment is becoming increasingly popular for biliary tract cancer, as it offers several advantages over other treatment options. One of the main advantages of the oral route of administration is that it is more convenient and less invasive than other treatment options. For example, patients who receive oral chemotherapy do not need to visit the hospital or clinic for treatment, and can instead take their medication at home.
Middle East Biliary Tract Cancers (BTCs) Market Report Coverage
“Saudi Arabia dominated the Middle East Biliary Tract Cancers (BTCs) market in 2022”
The Saudi Arabia biliary tract cancer market is expected to be driven by several factors in the coming years, including the increasing use of advanced treatment options, such as chemotherapy, radiation therapy, and surgery, as well as the growing demand for targeted therapies and immunotherapies. In addition to these factors, the Saudi Arabia biliary tract cancer market is also driven by the increasing investment in healthcare infrastructure and research and development, as well as the growing awareness of the importance of early detection and treatment of the disease.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The Middle East Biliary Tract Cancers (BTCs) market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Middle East Biliary Tract Cancers (BTCs) Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the Middle East Biliary Tract Cancers (BTCs) market were the three major steps undertaken to create and analyze the adoption of Middle East Biliary Tract Cancers (BTCs) in major regions. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the middle east biliary tract cancers (BTCs) market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the middle east biliary tract cancers (BTCs) market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the middle east biliary tract cancers (BTCs) market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as treatment type and route of administration. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the middle east biliary tract cancers (BTCs) market. Further, we conducted factor analysis using dependent and independent variables such as product type, application, and distribution channel of the middle east biliary tract cancers (BTCs) market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the middle east biliary tract cancers (BTCs) market sector.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Middle East Biliary Tract Cancers (BTCs) market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the middle east biliary tract cancers (BTCs) market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the middle east biliary tract cancers (BTCs) market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the middle east biliary tract cancers (BTCs) market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the treatment type and route of administration in the middle east biliary tract cancers (BTCs) market.
The main objective of the Middle East Biliary Tract Cancers (BTCs) Market Study
The current & future market trends of the middle east biliary tract cancers (BTCs) market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the middle east biliary tract cancers (BTCs) market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the treatment type and route of administration
- Define and analysis of the regulatory framework for the middle east biliary tract cancers (BTCs) industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the middle east biliary tract cancers (BTCs) market for the major region
- Major countries of regions studied in the report include Saudi Arabia, UAE, Qatar, and Bahrain
- Company profiles of the middle east biliary tract cancers (BTCs) market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
